Aclaris Therapeutics, Inc. (ACRS)
NASDAQ·Healthcare·Biotechnology
$5.91
+6.87%
Mkt Cap $726.25M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$10.75
Range $10.00 – $12.00
Implied Upside
+82.0%
Consensus $10.75 vs current $5.91
NASDAQ·Healthcare·Biotechnology
$5.91
+6.87%
Mkt Cap $726.25M
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$10.75
Range $10.00 – $12.00
+82.0%
Consensus $10.75 vs current $5.91